2018 Satellite Symposia Schedule

Monday Dinner, February 5, 2018, 6:30 – 8:30 PM
Mitigating Bone Manifestations of Gaucher Disease: Contemporary Evidence and Future Considerations
CME Satellite Symposium. This activity was supported by an educational grant from Sanofi Genzyme.
Provided by Med-IQ.

Tuesday Breakfast, February 6, 2018, 6:30 – 7:30 AM
Normalization in Type 1 Gaucher Disease – Does it matter?
Supported by Shire.
This satellite was open only to registered attendees from outside the United States. International participants only.

Tuesday Breakfast, February 6, 2018, 6:30 – 7:30 AM
The Case for Cerdelga® (eliglustat): The Only First-Line Oral Treatment for Most Adults with Gaucher Disease
Supported by Sanofi Genzyme.

Tuesday Lunch, February 6, 2018, 11:45 AM – 12:45 PM
Changing lives: Long-term outcomes of MPS IVA & VI patients
Supported by BioMarin Pharmaceutical.

Tuesday Lunch, February 6, 2018, 11:45 AM – 12:45 PM
Advancing the Understanding in Rare Diseases: Acid Sphingomyelinase Deficiency, GBA-associated Parkinson’s Disease and Gaucher Disease Type 3
Supported by Sanofi Genzyme.

Tuesday Dinner, February 6, 2018, 6:30 – 8:30 PM
Responding to the Challenge of Pompe Disease
CME Satellite Symposium. Supported by an independent educational grant from Sanofi Genzyme.
Provided by EXCEL Continuing Education.

Wednesday Breakfast, February 7, 2018, 6:30 – 7:30 AM
Novel Treatment Approaches and Study Designs for Rare Diseases
Supported by Ultragenyx.

Wednesday Breakfast, February 7, 2018, 6:30 – 7:30 AM
More than a glycolipid storage disorder – the role of inflammation in Fabry disease
Supported by Shire.
This satellite was open only to registered attendees from outside the United States. International participants only.

Wednesday Lunch, February 7, 2018, 11:45 AM – 12:45 PM
Clinical experience with migalastat▼ in Europe for the treatment of Fabry disease in patients with amenable mutations
Supported by Amicus Therapeutics, Inc.
This satellite was open only to registered attendees from outside the United States. International participants only.

Wednesday Lunch, February 7, 2018, 11:45 AM – 12:45 PM
Cognitive impairment in patients with MPS II: From disease burden to cognitive testing
Supported by Shire.

Wednesday Dinner, February 7, 2018, 6:30 – 8:30 PM
The Lysosomal Disease Exchange: Optimizing Diagnosis and Future Management
CME Satellite Symposium.This activity was supported by an independent educational grant from Sanofi Genzyme.
Jointly provided by the Elsevier Office of Continuing Medical Education and Excerpta Medica.

Thursday Breakfast, February 8, 2018, 6:30 – 7:30 AM
Creating Hope for the Unreachable, Unprofitable and Unthinkable Patient
Sponsored by Care Beyond Diagnosis Foundation, in conjunction with the MPS Society UK and the European Gaucher Alliance.
Supported via unrestricted educational grants from Chiesi Farmaceutici, Shire and FYMCA Medical Ltd.

Thursday Breakfast, February 8, 2018, 6:30 – 7:30 AM
Genotype and phenotype in Fabry disease: Early manifestations, measurement of disease severity, and considerations for monitoring progression
Supported by Sanofi Genzyme.

Thursday Lunch, February 8, 2018, 11:45 AM – 12:45 PM
Genetics: Unlocking the Future of Pediatric Epilepsies, Insights from the CLN2 Experience
Supported by BioMarin Pharmaceutical.

Thursday Lunch, February 8, 2018, 11:45 AM – 12:45 PM
Early treatment of lysosomal disorders: a closer look at Fabry and Pompe disease
Supported by Amicus Therapeutics, Inc.

Registration for the 14th Annual Scientific Meeting and an official WORLDSymposium name badge were required to attend any of the satellite symposia. Titles and content for Satellite Symposia were posted as information became available.

These Satellite Symposia were not part of the official WORLDSymposium™ 2018 program, and WORLDSymposium did not approve or endorse any commercial products or services discussed during these Symposia or offered for sale by the corporate supporter of the Symposium. These Symposia may or may not offer CME credits; these sessions were not approved for CME through WORLDSymposium.